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Abstract 
We report a rare case of pancreatic acinar
cell carcinoma with widespread metastases in
a 68-year-old woman who presented with sub-
cutaneous  nodules  as  the  initial  symptom.
Computed  tomography  showed  a  pancreatic
mass with hepatic tumors and enlarged lymph
nodes  besides  ring-enhanced  subcutaneous
nodules.  Magnetic  resonance  diffusion-
weighted  imaging  detected  the  presence  of
lesions in other organs. Histological analysis
of a colonic polypoid lesion revealed carcinoma
with endocrine and acinar differentiation com-
patible with pancreatic origin. Regrettably, she
died of a cerebral infarction without any treat-
ment,  and  autopsy  findings  confirmed  our
diagnosis.
Introduction
Acinar cell carcinoma (ACC) of the pancreas
is a rare tumor accounting for up to 1% of pan-
creatic  exocrine  neoplasms.  Half  of  the
patients  have  advanced  disease  with  metas-
tases  or  a  locally  unresectable  tumor  at  the
time  of  diagnosis.  We  report  a  68-year-old
female patient with metastatic subcutaneous
nodules as the initial presentation of ACC, who
had widespread metastases to various organs.
Case Report
A 68-year-old woman presented with a four-
week history of anorexia, general fatigue, and
multiple subcutaneous nodules on the neck or
trunk (Figure 1). These nodules were elastic
and hard. Laboratory tests showed mild ane-
mia (hemoglobin 10.1 g/dL), and elevated lev-
els of CA19-9 (355.2 U/mL) and elastase-1 (750
ng/dL). Serum lipase, amylase, and the tumor
markers (CEA and AFP) were within the nor-
mal ranges. Computed tomography (CT) scan
showed ring-enhanced nodules in various sub-
cutaneous sites, including the neck, chest wall,
abdominal wall, back and hips (Figure 2C). CT
scan also showed a 3-cm mass in the tail of
pancreas  with  multiple  hepatic  tumors  (the
largest being 6 cm) and enlargement of the
peripancreatic or paraaortic lymph nodes (the
largest  being  3  cm)  (Figure  2A  and  2B).
Subsequently, magnetic resonance (MR) diffu-
sion-weighted imaging (DWI) confirmed these
tumors, and detected high-intensity lesions in
the spleen, kidney, adrenal gland, and bone,
suggesting possible metastatic tumors (Figure
2D, 2E, and 2F). Colonoscopy showed a poly-
poid lesion, measuring 7 mm in diameter, with
central  depression  in  the  transverse  colon
(Figure 3A). Histological analysis of the biopsy
specimen revealed carcinoma with endocrine
and  acinar  differentiation  compatible  with
pancreatic origin (Figure 3B). Taken together,
we made a clinical diagnosis of pancreatic ACC
with widespread metastases to various organs. 
Unexpectedly, she suffered a massive cere-
bral infarction 4 days after admission, and died
30 days later without receiving any treatment
for ACC. We performed an autopsy with the
approval  of  her  family.  Autopsy  revealed  a
tumor that spread from the body to the tail of
pancreas.  Macroscopically,  the  tumor  was  a
solid,  well  circumscribed,  and  fleshy  lesion
with a little haemorrhage (Figure 4A). Micro  -
scopically, the tumor was hypercellular, with
cords of cytologically uniform cells with granu-
lar eosinophilic apical cytoplasm reflecting the
accumulation  of  zymogen  granules  (Figure
4B).  Immunohistochemical  staining  verified
the presence of α-1 antitrypsin (Figure 4C).
These findings were consistent with those of
ACC. Autopsy also revealed a pathological diag-
nosis of the subcutaneous nodules as metasta-
tic disease. Moreover, it confirmed the metas-
tases  to  various  other  organs  including  the
liver,  lymph  nodes,  spleen,  kidneys,  adrenal
gland, bone, small intestine, colon, and brain.
Discussion
ACC of the pancreas accounts for approxi-
mately 1% of all exocrine pancreatic tumors.
1
The adult patients average about 60 years old,
and  males  are  more  commonly  affected.
1-3
Clinical symptoms are usually non-specific, for
example  anorexia,  weight  loss,  abdominal
pain,  nausea,  and  vomiting.  ACC  may  not
cause jaundice even when the tumor is located
in  the  head  of  pancreas.
1,2 ACC  occasionally
secretes pancreatic enzymes such as trypsin,
lipase, chymotrypsin and amylase,
4-6 and some
patients develop a distinctive syndrome of sub-
cutaneous fat necrosis and polyarthralgia by
over-production of lipase.
7-9The skin nodules of
this syndrome are commonly seen on the lower
extremities, and often mistaken for metastatic
disease.
2 However, ACC with skin metastases
has not been reported. In our patient, serum
lipase level was within the normal range, and
she had subcutaneous nodules on the neck or
trunk,  not  on  the  lower  extremities.  To  our
knowledge, this is the first report of ACC with
skin metastases.
ACC is a highly aggressive tumor. Half of the
patients have evidence of metastatic disease at
presentation,  and  an  additional  23%  subse-
quently developed metastases to the regional
lymph nodes and liver.
1 Several clinical studies
have reported that the lungs, spleen, and adre-
nal  gland  are  other  potential  sites.
4,10,11 Our
patient proved to have widespread metastases
to various organs including the skin, kidneys,
bone, small intestine, colon, and brain, in addi-
tion to the sites mentioned above. This finding
indicates that ACC can target these organs as
metastatic sites, and that ACC may be so indo-
lent that some patients present without specif-
ic symptoms even in advanced stage.
With regard to the treatment of ACC, surgi-
cal  resection  remains  the  best  therapy  for
those patients with local, resectable disease.
Recently,  resection  has  been  actively  per-
formed and improved survival.
2,3,12 Kitagami et
al. reported a 5-year survival rate of 43.9% in
the case of total resection.
12 Holen et al. report-
ed  a  median  actuarial  survival  rate  of  36
months for those patients initially treated by
operative resection.
2 Unfortunately, more than
70% the patients who undergo surgical resec-
tion are eventually confirmed to show recur-
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rent disease.
2 Chemotherapy and radiotherapy
are  other  therapeutic  options  when  ACC  is
unresectable or recurs after resection, but no
effective treatment strategies have been estab-
lished. Although various chemotherapies have
been performed, their results have been unsat-
isfied. Holen et al. reviewed 22 chemotherapy
regimens  administered  to  18  different  pa  -
tients, and reported that there were no com-
plete  response,  only  2  PRs  and  7  SDs.
2
Recently, only a few case reports have shown
the efficiency of neoadjuvant or adjuvant treat-
ment with chemotherapy or radiation.
13,14 Seth
et al. reported four patients underwent surgi-
cal  resection  after  successful  neoadjuvant
chemoradiation  using  5-fluorouracil,  gemc-
itabine, cisplatin and adriamycin.
13 Lee et al.
reported two PR cases of locally advanced ACC
treated by capecitabine and concurrent radio-
therapy.
14
Chemoradiation may be the best option for
the patients with unresectable yet locally con-
fined  disease.
2 Therefore,  it  is  important  to
know the accurate extent of disease in deter-
mining appropriate therapies. In our case, MR
DWI  detected  not  only  original  pancreatic
tumor,  but  also  metastatic  lesions  in  the
spleen, kidney, and adrenal gland, which CT
scan failed to show clearly. This indicates that
MR DWI can be a helpful imaging modality in
the choice of treatment or the early detection
of recurrence in ACC patients.
Our  patient  died  of  a  massive  cerebral
infarction without receiving any treatment for
ACC.  Stroke  is  a  frequent  complication  in
patients  with  cancer.  The  principal  mecha-
nisms  of  stroke  pathogenesis  have  been
reported to be nonbacterial thrombotic endo-
carditis (NBTE), diffuse intravascular coagula-
tion, and atherosclerosis.
15 NBTE is character-
ized  by  the  presence  of  relatively  acellular
aggregates of fibrin and platelets attached to
normal heart valves, and is often the cause of
cerebral  infarction.
15,16 In  our  patient,  the
autopsy revealed not the progression of metas-
tases in the brain, but cerebral infarction with
occlusive thrombus in the right posterior cere-
Case Report
Figure 1. Subcutaneous nodules on the neck or trunk.
Figure 2. Computed tomography showing a pancreatic mass (B-3) with multiple hepatic
tumors (A-1), enlarged lymph nodes (B-2), and ring-enhanced subcutaneous nodules (C-
4). Magnetic resonance diffusion-weighted imaging showing high-intensity lesions in the
adrenal gland (D-5), spleen (D-6), bone (D-7), and kidney (E-8, F-9).
Figure  4.  Autopsy  findings.  Macroscopic  finding:  pancreatic  tumor  (A).  Histological
analysis:  hematoxylin  and  eosin  staining  (B),  immunohistochemical  staining  for  ￿-1
antitrypsin (C).
Figure 3. Colonoscopy showing a polypoid
lesion  (A).  Histological  analysis:  hema-
toxylin and eosin staining (B). [page 178] [Rare Tumors 2010; 2:e62]
bral artery and NBTE with vegetation on the
mitral valve. Therefore, we considered that she
died of stroke induced by the cancer-related
hypercoagulable state.
In conclusion, we have reported a case of
pancreatic ACC with widespread metastases to
various organs. This is the first report of ACC
with  skin  metastases.  Recent  studies  have
clarified the characteristics of ACC, but ACC
has not been fully understood. Future studies
of more patients are needed.
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